Solid Biosciences Inc. — Director's Dealing 2020

Aug 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2020-08-12

Reporting Person: Ganot Ilan (Director, CEO & President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-12	Common Stock	M	800	—	Acquired	3737	Indirect
2020-08-13	Common Stock	S	299	$2.4409	Disposed	3483	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-12	Restricted Stock Units	$	M	800	Disposed		Common Stock (800)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1148007	Direct
Common Stock	290914	Indirect

Footnotes

F1: Restricted Stock units convert into common stock on a one-for-one basis.

F2: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units.

F3: Represents 1,087,376 shares held by Mr. Ganot as an individual, and 60,631 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.

F4: Represents 290,914 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.

F5: On August 12, 2019, the reporting person's wife was granted 1,600 restricted stock units. The restricted stock units vested in two equal installments on February 12, 2020 and August 12, 2020.